Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 12.4%
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 12.4%
Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) rose 12.4% during trading on Thursday . The stock traded as high as $0.25 and last traded at $0.25. Approximately 975 shares were traded during trading, a decline of 94% from the average daily volume of 15,412 shares. The stock had previously closed at $0.22.
Alpha Tau Medical Ltd.（纳斯达克股票代码：DRTSW — 获取评级）的股价在周四的交易中上涨了12.4％。该股交易价格高达0.25美元，最后一次交易价格为0.25美元。交易期间交易了约975股，较平均每日交易量15,412股下降了94％。该股此前收于0.22美元。
Alpha Tau Medical Trading Up 12.4 %
Alpha Tau Medical 交易量上涨了
The firm has a fifty day simple moving average of $0.33 and a 200 day simple moving average of $0.33.
该公司的五十天简单移动平均线为0.33美元，200天简单移动平均线为0.33美元。
Institutional Investors Weigh In On Alpha Tau Medical
机构投资者权衡阿尔法陶医疗
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Polar Asset Management Partners Inc. acquired a new stake in shares of Alpha Tau Medical in the first quarter worth $134,000. Walleye Capital LLC lifted its position in Alpha Tau Medical by 10.9% in the second quarter. Walleye Capital LLC now owns 204,285 shares of the company's stock worth $98,000 after purchasing an additional 20,096 shares during the period. Whitebox Advisors LLC bought a new position in Alpha Tau Medical in the third quarter worth $65,000. Chicago Partners Investment Group LLC bought a new position in Alpha Tau Medical in the first quarter worth $55,000. Finally, LMR Partners LLP lifted its position in Alpha Tau Medical by 67.4% in the third quarter. LMR Partners LLP now owns 112,986 shares of the company's stock worth $660,000 after purchasing an additional 45,500 shares during the period.
几家对冲基金和其他机构投资者最近修改了他们对该股的持有量。Polar Asset Management Partners Inc. 在第一季度收购了价值13.4万美元的Alpha Tau Medical股票Walleye Capital LLC在第二季度将其在Alpha Tau Medical的头寸提高了10.9％。Walleye Capital LLC在此期间又购买了20,096股股票后，现在拥有该公司204,285股股票，价值98,000美元。Whitebox Advisors LLC在第三季度收购了Alpha Tau Medical的新职位，价值65,000美元芝加哥合伙人投资集团有限责任公司在第一季度收购了Alpha Tau Medical的新头寸，价值55,000美元。最后，LMR Partners LLP在第三季度将其在Alpha Tau Medical的头寸提高了67.4％。LMR Partners LLP在此期间又购买了45,500股股票后，现在拥有该公司价值66万美元的112,986股股票。
Alpha Tau Medical Company Profile
Alpha Tau 医疗公司简介
(Get Rating)
（获取评分）
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.
Alpha Tau Medical Ltd. 是一家临床阶段的肿瘤治疗公司，在以色列和美国从事用于治疗实体癌的扩散性α-发射体放射疗法（Alpha dArT）的研究、开发和商业化。其 Alpha-dART 技术用于皮肤癌、口腔癌、胰腺癌和乳腺癌的临床试验；以及肝细胞癌、肺癌和前列腺癌的临床前研究。
Read More
阅读更多
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
- Finding New Technology to Invest in: A Guide
- Genuine Parts Company Is Genuinely A Good Buy
- Healthcare Sector: Overview and Keys to Investing
- Can D.R. Horton Shares Raise The Roof, Or Is This The Ceiling?
- American Express Growth Riding On Joyful Consumer Spending
- 免费获取 StockNews.com 关于 Alpha Tau Medical (DRTSW) 的研究报告的副本
- 寻找可供投资的新技术：指南
- 正品零件公司确实是个不错的选择
- 医疗保健行业：概述和投资关键
- D.R. Horton 的股票能否抬高屋顶，还是这是上限？
- 美国运通的增长取决于愉快的消费者支出
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Alpha Tau 医学日报的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Alpha Tau Medical及相关公司的最新新闻和分析师评级的简明每日摘要。